Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer.

Authors :: Arend RC
Londoño-Joshi AI
Gangrade A
Katre AA
Kurpad C
Li Y
Samant RS
Li PK
Landen CN
Yang ES
Hidalgo B
Alvarez RD
Straughn JM
Forero A
Buchsbaum DJ
Source :: Oncotarget [Oncotarget] 2018 Apr 10; Vol. 9 (27), pp. 19459. Date of Electronic Publication: 2018 Apr 10 (Print Publication: 2018).
Publication Year :: 2018
Abstract: [This corrects the article DOI: 10.18632/oncotarget.13466.].

Full Text Access

Tools